{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:59:34Z","timestamp":1791575974714,"version":"4.3.4"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"24","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chimeric oncoproteins resulting from fusion of MLL to a wide variety of partnering proteins cause biologically distinctive and clinically aggressive acute leukemias. However, the mechanism of MLL-mediated leukemic transformation is not fully understood. Dot1, the only known histone H3 lysine 79 (H3K79) methyltransferase, has been shown to interact with multiple MLL fusion partners including AF9, ENL, AF10, and AF17. In this study, we utilize a conditional Dot1l deletion model to investigate the role of Dot1 in hematopoietic progenitor cell immortalization by MLL fusion proteins. Western blot and mass spectrometry show that Dot1-deficient cells are depleted of the global H3K79 methylation mark. We find that loss of Dot1 activity attenuates cell viability and colony formation potential of cells immortalized by MLL oncoproteins but not by the leukemic oncoprotein E2a-Pbx1. Although this effect is most pronounced for MLL-AF9, we find that Dot1 contributes to the viability of cells immortalized by other MLL oncoproteins that are not known to directly recruit Dot1. Cells immortalized by MLL fusions also show increased apoptosis, suggesting the involvement of Dot1 in survival pathways. In summary, our data point to a pivotal requirement for Dot1 in MLL fusion protein\u2013mediated leukemogenesis and implicate Dot1 as a potential therapeutic target. Cancer Res; 70(24); 10234\u201342. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-10-3294","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T02:51:46Z","timestamp":1292381506000},"page":"10234-10242","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":153,"title":["Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes"],"prefix":"10.1158","volume":"70","author":[{"given":"Ming-Jin","family":"Chang","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Achille","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Rose","family":"Reisenauer","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Wen","family":"Chou","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"},{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy J.","family":"Zeleznik-Le","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"},{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Hemenway","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"},{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"},{"name":"Authors' Affiliations:\u20081Department of Biochemistry, Tulane University, New Orleans, Louisiana; 2Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas; 3Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; 4Department of Physiology and 5Proteomics Core Facility, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Departments of 6Medicine and 7Pediatrics, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois; and 8Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"2022061702424964200_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/genetics\/150.2.613","article-title":"Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae","volume":"150","author":"Singer","year":"1998","journal-title":"Genetics"},{"key":"2022061702424964200_bib2","doi-asserted-by":"crossref","first-page":"43296","DOI":"10.1074\/jbc.M405902200","article-title":"Structure of the conserved core of the yeast. Dot1p, a nucleosomal histone H3 lysine 79 methyltransferase","volume":"279","author":"Sawada","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061702424964200_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj20030839","article-title":"Structure and regulation of the mDot1 gene, a mouse histone H3 methyltransferase","volume":"377","author":"Zhang","year":"2004","journal-title":"Biochem J"},{"key":"2022061702424964200_bib4","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1101\/gad.1001502","article-title":"Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association","volume":"16","author":"Ng","year":"2002","journal-title":"Genes Dev"},{"key":"2022061702424964200_bib5","doi-asserted-by":"crossref","first-page":"30421","DOI":"10.1074\/jbc.C200366200","article-title":"Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase","volume":"277","author":"Lacoste","year":"2002","journal-title":"J Biol Chem"},{"key":"2022061702424964200_bib6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(02)00759-6","article-title":"Dot1p modulates silencing in yeast by methylation of the nucleosome core","volume":"109","author":"van Leeuwen","year":"2002","journal-title":"Cell"},{"key":"2022061702424964200_bib7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0960-9822(02)00901-6","article-title":"Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain","volume":"12","author":"Feng","year":"2002","journal-title":"Curr Biol"},{"key":"2022061702424964200_bib8","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/MCB.02076-07","article-title":"DOT1L\/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells","volume":"28","author":"Steger","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2022061702424964200_bib9","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1073\/pnas.0437846100","article-title":"Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast and mammalian cells: a potential mechanism for position-effect variegation","volume":"100","author":"Ng","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061702424964200_bib10","doi-asserted-by":"crossref","first-page":"18059","DOI":"10.1074\/jbc.M601903200","article-title":"Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"2022061702424964200_bib11","doi-asserted-by":"crossref","first-page":"F617","DOI":"10.1152\/ajprenal.00636.2009","article-title":"CREB trans-activation of disruptor of telomeric silencing-1 mediates forskolin inhibition of CTGF transcription in mesangial cells","volume":"298","author":"Yu","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022061702424964200_bib12","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1073\/pnas.0912041107","article-title":"Af9\/Mllt3 interferes with Tbr1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex","volume":"107","author":"B\u00fcttner","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061702424964200_bib13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"2022061702424964200_bib14","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/j.1742-4658.2010.07608.x","article-title":"Mixed lineage leukemia: roles in human malignancies and potential therapy","volume":"277","author":"Marschalek","year":"2010","journal-title":"FEBS J"},{"key":"2022061702424964200_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061702424964200_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1101\/gr.749203","article-title":"A highly efficient recombineering-based method for generating conditional knockout mutations","volume":"13","author":"Liu","year":"2003","journal-title":"Genome Res"},{"key":"2022061702424964200_bib17","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using galK selection","volume":"33","author":"Warming","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2022061702424964200_bib18","first-page":"8304","article-title":"Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable","volume":"14","author":"Monica","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2022061702424964200_bib19","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/MCB.22.18.6542-6552.2002","article-title":"MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function","volume":"22","author":"So","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2022061702424964200_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1535-6108(03)00019-9","article-title":"MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice","volume":"3","author":"So","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061702424964200_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nsmb.1714","article-title":"Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia","volume":"17","author":"Cierpicki","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"2022061702424964200_bib22","doi-asserted-by":"crossref","first-page":"e1000190","DOI":"10.1371\/journal.pgen.1000190","article-title":"The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure","volume":"4","author":"Jones","year":"2008","journal-title":"PLoS Genet"},{"key":"2022061702424964200_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1535-6108(03)00214-9","article-title":"Dimerization of MLL fusion proteins immortalizes hematopoietic cells","volume":"4","author":"Martin","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061702424964200_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1535-6108(03)00188-0","article-title":"Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias","volume":"4","author":"So","year":"2003","journal-title":"Cancer Cell"},{"key":"2022061702424964200_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2009-09-243386","article-title":"Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6","volume":"116","author":"Liedtke","year":"2010","journal-title":"Blood"},{"key":"2022061702424964200_bib26","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood.V90.12.4699","article-title":"Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13)","volume":"90","author":"Ida","year":"1997","journal-title":"Blood"},{"key":"2022061702424964200_bib27","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1073\/pnas.94.16.8732","article-title":"MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3)","volume":"94","author":"Sobulo","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061702424964200_bib28","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/MCB.22.18.6542-6552.2002","article-title":"MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function","volume":"22","author":"So","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2022061702424964200_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1182\/blood-2002-06-1785","article-title":"Common mechanism for oncogenic activation of MLL by forkhead family proteins","volume":"101","author":"So","year":"2003","journal-title":"Blood"},{"key":"2022061702424964200_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum Mol Genet."},{"key":"2022061702424964200_bib31","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1182\/blood-2008-04-154310","article-title":"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization","volume":"113","author":"Popovic","year":"2009","journal-title":"Blood"},{"key":"2022061702424964200_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MCB.17.1.81","article-title":"The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis","volume":"17","author":"Chang","year":"1997","journal-title":"Mol Cell Biol."},{"key":"2022061702424964200_bib33","first-page":"3159","article-title":"Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence","volume":"9","author":"Kamps","year":"1994","journal-title":"Oncogene"},{"key":"2022061702424964200_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/gb-2005-6-6-113","article-title":"Histone modifications: from genome-wide maps to functional insights","volume":"6","author":"van Leeuwen","year":"2005","journal-title":"Genome Biol"},{"key":"2022061702424964200_bib35","first-page":"4882","article-title":"Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements","volume":"63","author":"Tsutsumi","year":"2003","journal-title":"Cancer Res"},{"key":"2022061702424964200_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"2022061702424964200_bib37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1101\/gad.1898410","article-title":"Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)","volume":"24","author":"Mohan","year":"2010","journal-title":"Genes Dev"},{"key":"2022061702424964200_bib38","doi-asserted-by":"crossref","first-page":"35659","DOI":"10.1074\/jbc.M109.038448","article-title":"AF17 competes with AF9 for binding to Dot1a to up-regulate transcription of epithelial Na+ channel alpha","volume":"284","author":"Reisenauer","year":"2009","journal-title":"J Biol Chem"},{"key":"2022061702424964200_bib39","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"key":"2022061702424964200_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"2022061702424964200_bib41","doi-asserted-by":"crossref","first-page":"e1000249","DOI":"10.1371\/journal.pbio.1000249","article-title":"Misguided transcriptional elongation causes mixed lineage leukemia","volume":"7","author":"Mueller","year":"2009","journal-title":"PLoS Biol"},{"key":"2022061702424964200_bib42","doi-asserted-by":"crossref","first-page":"11966","DOI":"10.1074\/jbc.M110.101642","article-title":"Hsp90 directly modulates the spatial distribution of AF9\/MLLT3 and affects target gene expression","volume":"285","author":"Lin","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/24\/10234\/2642098\/10234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/70\/24\/10234\/2642098\/10234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T06:36:21Z","timestamp":1655447781000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/70\/24\/10234\/560829\/Histone-H3-Lysine-79-Methyltransferase-Dot1-Is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":42,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2010,12,14]]},"published-print":{"date-parts":[[2010,12,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-10-3294","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6502458.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389069","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389078.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389078","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389066","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389066.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389075","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389072","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389081","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6502458","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389069.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389072.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389075.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22389081.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}